Literature DB >> 23177985

The SLC10 carrier family: transport functions and molecular structure.

Barbara Döring1, Thomas Lütteke, Joachim Geyer, Ernst Petzinger.   

Abstract

The SLC10 family represents seven genes containing 1-12 exons that encode proteins in humans with sequence lengths of 348-477 amino acids. Although termed solute carriers (SLCs), only three out of seven (i.e. SLC10A1, SLC10A2, and SLC10A6) show sodium-dependent uptake of organic substrates across the cell membrane. These include the uptake of bile salts, sulfated steroids, sulfated thyroidal hormones, and certain statin drugs by SLC10A1 (Na(+)-taurocholate cotransporting polypeptide (NTCP)), the uptake of bile salts by SLC10A2 (apical sodium-dependent bile acid transporter (ASBT)), and uptake of sulfated steroids and sulfated taurolithocholate by SLC10A6 (sodium-dependent organic anion transporter (SOAT)). The other members of the family are orphan carriers not all localized in the cell membrane. The name "bile acid transporter family" arose because the first two SLC10 members (NTCP and ASBT) are carriers for bile salts that establish their enterohepatic circulation. In recent years, information has been obtained on their 2D and 3D membrane topology, structure-transport relationships, and on the ligand and sodium-binding sites. For SLC10A2, the putative 3D morphology was deduced from the crystal structure of a bacterial SLC10A2 analog, ASBT(NM). This information was used in this chapter to calculate the putative 3D structure of NTCP. This review provides first an introduction to recent knowledge about bile acid synthesis and newly found bile acid hormonal functions, and then describes step-by-step each individual member of the family in terms of expression, localization, substrate pattern, as well as protein topology with emphasis on the three functional SLC10 carrier members.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177985     DOI: 10.1016/B978-0-12-394316-3.00004-1

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN: 1063-5823            Impact factor:   3.049


  45 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

2.  A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.

Authors:  Mao-Xu Ge; Wei-Xiao Niu; Jin-Feng Ren; Shi-Ying Cai; Dong-Ke Yu; Hong-Tao Liu; Na Zhang; Yi-Xuan Zhang; Yu-Cheng Wang; Rong-Guang Shao; Ju-Xian Wang; Hong-Wei He
Journal:  Acta Pharmacol Sin       Date:  2018-12-20       Impact factor: 6.150

Review 3.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.

Authors:  Eric K Kwong; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

4.  Na+-taurocholate cotransporting polypeptide (NTCP/SLC10A1) ortholog in the marine skate Leucoraja erinacea is not a physiological bile salt transporter.

Authors:  Dongke Yu; Han Zhang; Daniel A Lionarons; James L Boyer; Shi-Ying Cai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-11       Impact factor: 3.619

5.  Inflammation-associated upregulation of the sulfated steroid transporter Slc10a6 in mouse liver and macrophage cell lines.

Authors:  Astrid Kosters; Demesew F Abebe; Julio C Felix; Paul A Dawson; Saul J Karpen
Journal:  Hepatol Res       Date:  2015-11-19       Impact factor: 4.288

6.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.

Authors:  Jiwon Lee; Li Zong; Alexander Krotow; Yanli Qin; Lucy Jia; Jiming Zhang; Shuping Tong; Jisu Li
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

8.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

Review 9.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

Review 10.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.